The important role of molecular profiling to guide therapy in metastatic breast cancer patients and the emerging role of liquid biopsy in the detection of resistance mechanisms with ultrasensitive techniques
Year: 2026
Type: article
Source: European Journal of Cancer
Institution: Institut Català d'Oncologia
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: metastatic breast cancer, liquid biopsy, tumor molecular profiling, endocrine therapy resistance, CDK4/6 inhibitors, PIK3CA mutation, ERBB2 mutations, ESR1 mutations, acquired resistance, PI3K inhibitors, AKT inhibitors, tyrosine kinase inhibitors, selective estrogen receptor modulators, luminal breast cancer, targeted therapy
Open Access status: closed
OpenAlex ID: W7141071076
